As part of the House’s “China Week”—focusing on legislation to curb threats from Beijing—the House passed the BIOSECURE Act (H.R. 8333) on September 9 with strong bipartisan support (in a 306–81 vote). If signed into law, this legislation would prohibit federal contracting with, or procurement from, certain biotechnology companies connected to foreign adversaries, including several explicitly named Chinese companies and entities associated with those companies or the Chinese government….
By: Manatt, Phelps & Phillips, LLP
By: Manatt, Phelps & Phillips, LLP
